ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.
Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological, genetic, and epigenetic levels. Exome sequencing has identified ARID1A as a novel tumor suppressor gene coding for a chromatin remodeling protein that is mutated in UBC. Here, we assess ARID1A alterations in two series o...
Guardado en:
Autores principales: | Cristina Balbás-Martínez, María Rodríguez-Pinilla, Ariel Casanova, Orlando Domínguez, David G Pisano, Gonzalo Gómez, Josep Lloreta, José A Lorente, Núria Malats, Francisco X Real |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b881dfb55ce4481c96fc619a4d0cc19a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.
por: Maciej J Czachorowski, et al.
Publicado: (2012) -
Primary Chondrosarcoma in L-shaped Crossed Fused Renal Ectopia Coexisting with Papillary Urothelial Carcinoma in Urinary Bladder – An Enigmatic Entity with Poor Prognosis
por: Mayank Kumar, et al.
Publicado: (2021) -
Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.
por: Shinsuke Oda, et al.
Publicado: (2021) -
ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
por: Erica di Martino, et al.
Publicado: (2019) -
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
por: Young H Lee, et al.
Publicado: (2021)